UK diagnostics firm in share placement

Country

United Kingdom

Angle Plc, a specialist medical technology company listed on the AIM market in London, has placed about 15.8 million new shares with institutional investors raising £10.2 million in order to commercialise a liquid biopsy test for cancer based on the detection of circulating tumour cells.